Time:
All Today Tomorrow This Week This Month

High-Titer Lentivirus Solutions in 5 Days: Break Production Barriers for CGT

Watch this webinar to gain insights into lentivirus innovations driving breakthroughs in in vivo CAR-T and gene delivery.

09-04-2025 Chuanxin Liu, PhD, Head of Viral Vector R&D, GenScript Biotech Corporation

Learn More

Maximizing PK and ADA Evaluation Efficiency with Our Cutting-Edge Rabbit Antibody Development Technology

Discover how GenScript's cutting-edge rabbit anti-idiotypic antibody (Anti-ID Ab) development technology enhances pharmacokinetics (PK) and anti-drug antibody (ADA) assays.

10-18-2024 Dr. Hui Foon Tan, Sr. Global Product Manager - Antibody, GenScript Biotech

Learn More

Accelerating Therapeutic Antibody Development: Discover Our Cutting-Edge CHO Expression Technology

Antibodies play a crucial role in biological and biochemical research, and their importance in therapeutic applications is increasing.

07-18-2024 Dr. Yerim Kwon, Field Application Scientist, APAC region

Learn More

AI-based Antibody Therapeutics Developability Assessment and Its Engineering

Monoclonal antibodies (mAbs) have become essential in treating a wide spectrum of diseases, with over 100 therapeutic antibody products now approved and commercially available.

06-21-2024 Dr. Carter Hao

Learn More

Bispecific Antibody Overview & CrossMab Technology | GenScript

The webinar will introduce the advantages of bispecific antibodies (bsAbs), their mechanism of action (MOA), and the development history of bsAb platform.

06-18-2024 Dr. Wang Sai, Senior Scientist (Protein), GenScript

Learn More

Development of CAR-T Cells for T-ALL Targeting CCR9

Discover a groundbreaking webinar exploring the developments in cancer immunotherapy targeting CC chemokine receptor 9 (CCR9), a potential breakthrough for T-cell acute lymphoblastic leukemia (T-ALL). 

03-06-2024 Dr. Paul Maciocia, Clinical Scientist and Honorary Consultant Haematologist, Cancer Institute, University College London

Learn More

1 2 3 4
...
7